MedTrace Logo

Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity

NCT07317128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-05-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the clinical efficacy of test fluoride dentifrice in reducing Dentin Hypersensitivity (DH) with that of a standard fluoride dentifrice, as measured by evaporative air sensitivity after 12 weeks twice daily brushing.

Conditions

  • Dentin Sensitivity

Interventions

DRUG

Test Dentifrice

Dentifrice containing 1450 parts per million (ppm) fluoride as sodium monofluorophosphate.

DRUG

Colgate Sensitive ProRelief

A marketed dentifrice.

DRUG

Colgate Triple Protection

A marketed dentifrice.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Principal Investigators

  • Minquan Du, DSS, PhD · Wuhan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-20
Primary Completion
2013-06-08
Completion
2013-06-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317128 on ClinicalTrials.gov